GlassScriptPhysician profile
Carlin B Hollar
NPI 1982766309
$1,262.88
in general payments reported to CMS, 2019-2025
18 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $19.99 · 2021: $111 · 2022: $195 · 2023: $396 · 2024: $288 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.75 |
| Education | $209.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $558.20 | 2019-2024 | Tremfya |
| Genzyme Corporation | $129.17 | 2020-2025 | |
| Galderma Laboratories, L.P. | $76.67 | 2022-2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $73.96 | 2019-2023 | Dupixent |
| Dermavant Sciences, INC. | $68.84 | 2022-2023 | Vtama |
| Abbvie INC. | $68.56 | 2021-2023 | |
| Incyte Corporation | $55.97 | 2022-2024 | Opzelura |
| Pfizer INC. | $36.07 | 2023-2024 | |
| Arcutis Biotherapeutics, INC. | $32.81 | 2023 | |
| Botanix Sb INC | $23.10 | 2025 | Sofdra |
| Sun Pharmaceutical Industries INC. | $21.88 | 2024 | |
| Lilly USA, LLC | $21.50 | 2022 | |
| Lnhc, INC | $18.16 | 2025 | Zelsuvmi |
| Amgen INC. | $18.15 | 2022 | |
| Ucb, INC. | $17.14 | 2025 | Bimzelx |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.65 | 2024 | Sotyktu |
| Celgene Corporation | $14.96 | 2019 | |
| Leo Pharma INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlin Hollar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.